Panel Discussion: Transforming Patient Monitoring Through Innovation in Liquid Biopsy Analytes, Detection Sensitivity & Data Interpretation
- What are the most impactful recent innovations in liquid biopsy biomarkers, and how can these be robustly validated and effectively integrated into clinical trial designs?
- How can drug-diagnostic stakeholders build high-value, collaborative frameworks to advance liquid biopsy technologies, particularly in improving detection sensitivity, standardization, and data interpretation?